AFIP foundation hearts the heart

The AFIP Foundation connects researchers and patients with atrial fibrillation. We have an ANBI status, which means that we are committed to the public interest. The AFIP Foundation’s mission is to improve the treatment of atrial fibrillation through co-creation. A team of research groups led by Dr. Bianca Brundel and Dr. Natasja de Groot, conducts innovative research into the mechanism, diagnostics and possible medicines of AF.

Our main goal is to make atrial fibrillation more treatable. Your role in that is vital, since without donations we would not be able to conduct our unprecedented research. Your participation on the AFIP forum sharing experiences with fellow patients and researchers, is also key. Together we will learn to better understand atrial fibrillation.

Atrial-Fibrillation-Research

Atrial fibrillation from A to Z

No less than 37 million people worldwide know that they have atrial fibrillation. However, there are still thousands of people without a diagnosis. In the AFIP data base you can read all about the most common heart rhythm disorder, anything from symptoms to possible treatments.

Most searched topics

What is atrial fibrillation?

What is atrial fibrillation?
Written by: Prof. Dr. Bianca Brundel

Atrial fibrillation is the cardiac arrhythmia of the 21st century Currently, atrial fibrillation (also called AF) is one of the most common cardiac arrhythmias. Although it is not life-threatening, it

Atrial fibrillation and genetics

Atrial fibrillation and genetics
Written by: Prof. Dr. Bianca Brundel

Atrial fibrillation is genetic in 20% of patients In the genetic variant of atrial fibrillation, there is a gene abnormality. Patients sometimes do not notice the common symptoms of atrial

COVID-19 and atrial fibrillation

COVID-19 and atrial fibrillation
Written by: Prof. Dr. Bianca Brundel

How does coronavirus affect people with atrial fibrillation? Since February 2020, coronavirus has affected everyone's lives. Nowadays, thanks to the development of vaccines with a portion of the SARS-CoV-2 virus

Atrial fibrillation and stress

Atrial fibrillation and stress
Written by: Prof. Dr. Bianca Brundel

According to patients, stress is the most important factor for the onset of an atrial fibrillation attack A poll conducted on the AFIP website revealed that 25% of the patients

Successful studies
thanks to the AFIP community

The AFIP community is an imperative link in research into atrial fibrillation. Thanks to your experiences, donations and participation, we have been able to set up the studies below.

GGA: a new drug to treat atrial fibrillation?

GGA: a new drug to treat atrial fibrillation?
Written by: Myrthe Kuipers

GGA protects against atrial fibrillation in experimental models Prof. dr. In 2006, Bianca Brundel was the first researcher to demonstrate that GGA successfully protects one from atrial fibrillation in various

L-Glutamine and its role in atrial fibrillation

L-Glutamine and its role in atrial fibrillation
Written by: Myrthe Kuipers

Heat Shock Proteins Protect Against Atrial Fibrillation in Experimental Models For 15 year we have been aware of the fact that substances that increase the so-called Heat Shock Proteins (HSP)

Projects we are doing thanks to your donation

In addition to doing innovative research, the AFIP Foundation is committed to atrial fibrillation in many ways. These are our latest projects.

Trial

L-Glutamine study

L-Glutamine restores energy levels and allows for potentially increased protection against atrial fibrillation.

Trial

GGA study

This medicine aids in the reparation of cell damage and helps protect against atrial fibrillation in experimental models.

Man in Lab

Opening

Genetic AF clinic

We heard you. A significant number of AF patients indicated AF runs in the family and now we’re opening Europe’s first genetic AF clinic.

Agnes Muskens verpleegkundige stichting AFIP

Hire

Agnes Muskens

Because of your donation AFIP was able to hire Agnes: our patient communication superstar.

News and Articles

Read all about the latest developments regarding atrial fibrillation, and explore the insights of opinion leaders and prominent researchers as well as any other related news.

Trial: Using Vitamin B3 To Treat Atrial Fibrillation in Heart Failure Patients

Trial: Using Vitamin B3 To Treat Atrial Fibrillation in Heart Failure Patients
Written by: Prof. Dr. Bianca Brundel , , ,

The prevalence of atrial fibrillation (AF) in patients with heart failure (HF) is associated with an extra increase in risk for stroke development, number of hospitalisations and mortality. Given the

The Role of Desmin Variants In Familial Atrial Fibrillation

The Role of Desmin Variants In Familial Atrial Fibrillation
Written by: Wei Su , , , ,

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the Western world. AF is closely correlated with traditional risk factors. Traditional risk factors include lifestyle related hypertension, diabetes

Lifestyle Changes Today Could Mean No AF Tomorrow

Lifestyle Changes Today Could Mean No AF Tomorrow
Written by: Prof. Dr. Bianca Brundel

This article has been featured in Nature Reviews Disease Primers. After extensive research into the socioeconomic and geographic risk factors associated with Atrial Fibrillation (AF), one cannot deny their role

Atrial Fibrillation (AFib) Diagnosis And Treatments Need a New Holistic Approach

Atrial Fibrillation (AFib) Diagnosis And Treatments Need a New Holistic Approach
Written by: Prof. Dr. Bianca Brundel ,

This article has been featured in Nature Reviews Disease Primers. Atrial Fibrillation (AF), is the most common heart disease nowadays, affecting around 7.6 million people only in the EU, most

Personalised Atrial Fibrillation Fingerprinting: role in diagnosing disease

Personalised Atrial Fibrillation Fingerprinting: role in diagnosing disease
Written by: Prof. Dr. Bianca Brundel , ,

This article has been featured in Nature Reviews Disease Primers. When Atrial Fibrillation (AF) is diagnosed, you only have information on having the arrhythmia or you don't. There isn't enough